ANGLE (LON:AGL) Shares Up 14.3% – Should You Buy?

ANGLE plc (LON:AGL) shares were up 14.3% during mid-day trading on Tuesday . The stock traded as high as GBX 12.99 ($0.16) and last traded at GBX 12.58 ($0.16). Approximately 1,308,476 shares changed hands during mid-day trading, an increase of 96% from the average daily volume of 666,717 shares. The stock had previously closed at GBX 11 ($0.14).

Analyst Upgrades and Downgrades

Separately, Berenberg Bank reissued a “buy” rating and set a GBX 70 ($0.86) price target on shares of ANGLE in a research report on Thursday, September 26th.

ANGLE Price Performance

The company has a market cap of £38.70 million, a PE ratio of -171.43 and a beta of 0.22. The company has a debt-to-equity ratio of 17.22, a current ratio of 5.19 and a quick ratio of 6.18. The stock’s 50-day moving average is GBX 10.70 and its 200 day moving average is GBX 11.22.

About ANGLE

ANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products in Europe, North America, and the United Kingdom. The company develops and commercializes Parsortix cell separation system, which captures and harvests circulating tumor cells in metastatic breast cancer patient blood; and HyCEAD.